查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552894

生物骇客市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场进行预测，2024-2030 年

Biohacking Market Size, Share & Trends Analysis Report By Product, By Application (Synthetic Biology, Drug Testing), By End-use (Hospitals & Clinics, Pharma & Biotech Companies), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格
简介目录

生物黑客市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球生物骇客市场规模将达到678.6亿美元，2024年至2030年复合年增长率为18.6%。

市场参与者的各种措施和生物骇客资金的增加是推动市场成长的主要因素。采用生物骇客实践可以帮助个人实现精神、身体和情绪的改变，例如降低疾病的风险，特别是遗传相关疾病、减重和减少忧郁症症状，并改善身体健康，例如由于血压升高而导致的血压升高。

全球市场受到 COVID-19 大流行的严重影响。 COVID-19 对市场的主要影响包括供应链中断、销售下降和需求疲软。然而，该行业的生物骇客正在投资研究工作来开发 COVID-19 疫苗和检测套组。这抵消了 2020 年的市场成长。生物骇客购买设备和材料需要基本资金。除了群众集资之外，这些机构的大部分活动都是透过会员费和研讨会参加费自筹资金。此外，个人捐款也用于筹募资金。

睡眠改善与睡眠追踪平台 Oura Ring 的製造商 Oura Health 于 2018 年 12 月在默沙东资本 (MSD Capital)主导的B 轮资金筹措中筹集了 2,000 万美元。全球市场竞争相当激烈。大多数市场参与者正在实施新产品推出、收购和联盟等策略，以获得彼此的竞争优势。例如，2020 年 9 月，苹果与新加坡政府合作，利用 Apple Watch 发起了一项全国健康管理措施。为此，该国努力利用技术并为其公民提供先进的健康福利。

生物黑客市场报告亮点

  • 2023年穿戴领域占29.9%。该市场当前的趋势主要是由添加健康功能、结合人工智慧提供个人化提案以及向医疗保健专业人员发送即时资料以实现更快的干预和更好的患者治疗结果所驱动的。
  • 2023年，诊断和治疗领域占最大收益占有率，超过32.3%。这是由于越来越多地使用生物骇客实践，例如精神药物和穿戴式技术来增强身体。
  • 2023年，医院和诊所部门占最大份额，达40.3%。该领域的增长归因于慢性病及其治疗的增加。
  • 北美生物骇客市场在 2023 年以 36.7% 的市场占有率占据主导地位。这是由于慢性病盛行率不断上升、生物骇客意识不断增强以及该地区人口老化。
  • 亚太生物骇客市场预计到 2023 年将以 20.6% 的复合年增长率大幅成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章生物黑客市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 生物骇客市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 生物骇客市场：依产品估算与趋势分析

  • 细分仪表板
  • 生物骇客市场：2023 年和 2030 年产品变化分析
  • 穿戴式的
  • 植入
  • 基因改造试剂套件
  • 聪明药
  • 补充品
  • 行动应用程式
  • 其他的

第五章生物骇客市场：按应用估计和趋势分析

  • 细分仪表板
  • 生物骇客市场：2023 年和 2030 年应用变化分析
  • 合成生物学
  • 基因工程
  • 法医学
  • 诊断和治疗
  • 药物测试

第六章生物骇客市场：区域估计与趋势分析

  • 2023 年和 2030 年生物黑客市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Apple Inc.
    • THE ODIN
    • Thync Inc.
    • Fitbit, Inc.
    • Moodmetric
    • HVMN Inc.
    • Muse（Interaxon Inc.）
    • Thriveport, LLC
    • TrackMyStack
    • OsteoStrong
简介目录
Product Code: GVR-4-68039-479-7

Biohacking Market Growth & Trends:

The global biohacking market size is anticipated to reach USD 67.86 billion by 2030, registering a CAGR of 18.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Various initiatives by market players and rising funds for biohacking are the major factors fueling the market growth. The adoption of biohacking practices is growing due to their potential applications in decreasing the risk of developing a disease, especially genetically associated diseases, helping an individual to achieve mental, physical, or emotional changes, such as weight loss or reducing depression symptoms; and optimize general functions of the body, such as blood pressure.

The global market has been significantly affected by the COVID-19 pandemic. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, and low demand. However, biohackers in the industry are investing in some research activities for the development of COVID-19 vaccines as well as test kits. This neutralized the market growth in 2020. For the purchase of equipment and materials, biohackers require basic funding. Other than crowdfunding, most of the activities at these labs are self-funded through membership and workshop fees. Furthermore, private donations are also used for raising money.

Oura Health, manufacturer of the Oura ring, a sleep-improvement and sleep tracking platform, raised USD 20 million in Series B funding led by MSD Capital in December 2018. The global market is fairly competitive. Most of the market players have undertaken strategies, such as new product launches, acquisitions, and partnerships, to gain a competitive edge over each other. For instance, in September 2020, Apple Inc. partnered with the government of Singapore for launching a national health initiative using Apple Watch. With this, the country made an effort to leverage technology for delivering advanced health benefits to its citizens.

Biohacking Market Report Highlights:

  • The wearables segment accounted for a share of 29.9% in 2023. Current developments in this market mainly focus on technological progress, such as adding additional health functions, incorporating Artificial Intelligence for personalized suggestions, and sending live data to healthcare professionals for prompt interventions and better patient results.
  • The diagnosis and treatment segment held the largest revenue share of over 32.3% in 2023 due to the high usage of biohacking practices, such as nootropics and wearable technologies, for body enhancement purposes.
  • The hospitals and clinics segment held the largest share of 40.3% in 2023. The segment growth is credited to the increase in chronic diseases and their treatment.
  • North America biohacking market dominated the market in 2023 with a market share of 36.7%. This is due to the increasing prevalence of chronic illnesses, increase in the awareness of biohacking, and an aging population in the region.
  • Asia Pacific Biohacking market is anticipated to witness significant growth in 2023 with a CAGR of 20.6% attributing to the rise in healthcare expenditure that has led to economic growth in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biohacking Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Biohacking Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Biohacking Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biohacking Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Wearables
    • 4.3.1. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.1. Wearable Neurotech
    • 4.3.2. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.1. Oura ring
    • 4.3.3. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.1. Muse Headband
    • 4.3.4. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.1. Others
  • 4.4. Implants
    • 4.4.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1. Blood test Implants
    • 4.4.2. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.1. Circadia Implants
    • 4.4.3. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.1. NFC and RFID tags
    • 4.4.4. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.1. Others
  • 4.5. Gene Modification Kits
    • 4.5.1. Gene Modification Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Smart Drugs
    • 4.6.1. Smart Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Supplements
    • 4.7.1. Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Mobile Apps
    • 4.8.1. Mobile Apps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biohacking Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biohacking Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Synthetic Biology
    • 5.3.1. Synthetic Biology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Genetic Engineering
    • 5.4.1. Genetic Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Forensic Science
    • 5.5.1. Forensic Science Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diagnosis & Treatment
    • 5.6.1. Diagnosis & Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Drug Testing
    • 5.7.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biohacking Market: Regional Estimates & Trend Analysis

  • 6.1. Biohacking Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. UAE Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Apple Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. THE ODIN
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Thync Inc.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Fitbit, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Moodmetric
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. HVMN Inc.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Muse (Interaxon Inc.)
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Thriveport, LLC
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. TrackMyStack
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. OsteoStrong
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiative